USPTO serial 78672362
NUSLEEP
Reviewed by CopyMark Law Group
Status 605
- Filing date
- Status date
- Registration date
- —
- Examiner
- MICHOS, JOHN E
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NUSLEEP?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Richard A. Friedman
RICHARD A FRIEDMAN PFIZER INC201 TABOR RD # AG1000MORRIS PLAINS, NJ 07950-2693UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISEASE, CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS, NEUROLOGICAL DISORDERS, UROGENITAL DISORDERS, GASTROINTESTINAL DISORDERS, MUSCULOSKELETAL DISORDERS, ALLERGIES, DIABETES, HYPERTENSION, ERECTILE DYSFUNTION, SEXUAL DYSFUNCTION, STROKE, CANCER, MIGRAINES, PAIN, OBESITY, INFLAMMATION, INFLAMMATORY DISEASES, RESPIRATORY DISEASES, INFECTIOUS DISEASES, IMMUNOLOGICAL DISORDERS, VIRAL DISORDERS, FUNGAL DISORDERS; PHARMACEUTICAL PREPARATIONS, NAMELY CHOLESTEROL PREPARATIONS, SMOKING CESSATION PREPARATIONS, DERMATOLOGICAL PREPARATIONS, GYNECOLOGICAL PREPARATIONS, OSTEOPOROSIS PREPARATIONS, OPTHALMOLOGICAL PREPARATIONS AND PREMENSTRUAL SYNDROME DISORDERS, PHARMACEUTICAL SLEEP-AID PREPARATIONS | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 12, 2007 | MAB5 | ABANDONMENT NOTICE MAILED - AFTER PUBLICATION | — |
| Jul 12, 2007 | ABN5 | ABANDONMENT - AFTER PUBLICATION | — |
| Jul 12, 2007 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Apr 13, 2007 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Apr 13, 2007 | EXT2 | SOU EXTENSION 2 FILED | — |
| Apr 13, 2007 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jan 16, 2007 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 25, 2006 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 25, 2006 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 25, 2006 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 20, 2006 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 28, 2006 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 8, 2006 | NPUB | NOTICE OF PUBLICATION | — |
| Feb 14, 2006 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Feb 10, 2006 | ALIE | ASSIGNED TO LIE | — |
| Feb 6, 2006 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 6, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 21, 2005 | NWAP | NEW APPLICATION ENTERED | — |